Zoledronic Acid: all 272 studies that test it
Page 3 of 3. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.
- Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior YearCompletedNCT00424983Phase 1
- ZANTE: Zometa and Taxotere in Hormone Refractory Prostate CancerCompletedNCT00415779Phase 1
- HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.Active, not recruitingNCT00412022Phase 3
- Maintaining Bone Strength in Men With Prostate CancerTerminatedNCT00391950Phase 3
- Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate CancerCompletedNCT00391690Phase 4
- Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving LetrozoleCompletedNCT00376740Phase 3
- Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate CancerCompletedNCT00375648Phase 3
- Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone LesionsTerminatedNCT00372710Phase 3
- Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal EventsCompletedNCT00346242Phase 4
- Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast CancerCompletedNCT00334139Phase 4
- Use of Bisphosphonates in the Treatment of Osteopathy After Liver TransplantationStatus unknownNCT00302484Not applicable
- S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the BoneWithdrawnNCT00301886Phase 3
- ZOMETA® (Zoledronic Acid) for Prevention of Bone MetastasesTerminatedNCT00294437Phase 3
- A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM)CompletedNCT00287261Phase 2
- Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3TerminatedNCT00278434Phase 1
- Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug EfficacyActive, not recruitingNCT00268476Phase 2/3
- Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases PalliationCompletedNCT00264420Phase 1
- Higher Frequency Zoledronic Acid in the Treatment of Multiple MyelomaCompletedNCT00263484Phase 2
- Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.TerminatedNCT00258765Phase 2
- Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell DisordersTerminatedNCT00258258Phase 1
- Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant TherapyCompletedNCT00247650Phase 2
- Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone MetastasesCompletedNCT00242554Phase 4
- Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.WithdrawnNCT00242528Phase 4
- Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast CancerCompletedNCT00242203Phase 2
- Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone MetastasisCompletedNCT00241111Phase 4
- Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone MetastasisCompletedNCT00237159Phase 4
- Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone OrchiectomyCompletedNCT00237146Phase 4
- Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate CancerTerminatedNCT00226954Phase 2
- Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate CancerCompletedNCT00219271Phase 4
- Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple MyelomaCompletedNCT00219258Phase 3
- Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone MetastasesCompletedNCT00219219Phase 4
- Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple MyelomaTerminatedNCT00216151Phase 2
- Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone InvolvementCompletedNCT00206388Phase 1
- Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast CancerCompletedNCT00202059Phase 3
- RADAR Trial - Randomised Androgen Deprivation and RadiotherapyCompletedNCT00193856Phase 3
- Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate CancerCompletedNCT00181584Phase 2
- Atrasentan and Zometa for Men With Prostate Cancer Metastatic to BoneCompletedNCT00181558Phase 2
- Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone MarrowTerminatedNCT00172068Phase 2
- Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone TherapyCompletedNCT00172055Phase 3
- Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic AcidCompletedNCT00172029Phase 4
- A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as BisphosphonatesCompletedNCT00172016Phase 4
- Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone MetastasisCompletedNCT00172003Phase 4
- Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone LesionsCompletedNCT00171964Phase 4
- The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting OsteoporosisCompletedNCT00171639Phase 3
- Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the ProstateCompletedNCT00151073Phase 2
- To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal WomenCompletedNCT00145275Phase 3
- Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis ImperfectaCompletedNCT00131118Phase 2
- Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone LesionsTerminatedNCT00130494Phase 3
- Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the CommunityCompletedNCT00126386Not applicable
- The Effect of Zoledronic Acid on Bone Density in Liver Transplant PatientsCompletedNCT00114556Phase 4
- Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast DensityCompletedNCT00114270Not applicable
- Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast CancerCompletedNCT00107263Phase 3
- Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral DensityStatus unknownNCT00102908Phase 2
- Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced OsteoporosisCompletedNCT00100620Phase 3
- A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral BisphosphonateCompletedNCT00100555Phase 3
- Non-small Cell Lung Cancer RegistryCompletedNCT00099541Phase 4
- Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in MenCompletedNCT00097825Phase 3
- Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic AcidCompletedNCT00097812Phase 3
- A Prostate Cancer Study in Men Undergoing Androgen Deprivation TherapyCompletedNCT00087659Not applicable
- Non-small Cell Lung Cancer Study US75 (Z-PACT)CompletedNCT00086268Phase 3
- Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast CancerStatus unknownNCT00072020Phase 3
- The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation TherapyCompletedNCT00063609Phase 4
- Bisphosphonate Treatment of Osteogenesis ImperfectaCompletedNCT00063479Phase 2
- Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone MetastasesCompletedNCT00060138Phase 1/2
- HORIZON-PFT: Pivotal Fracture TrialCompletedNCT00049829Phase 3
- Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast CancerCompletedNCT00049452Phase 3
- Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip FractureCompletedNCT00046254Phase 3
- Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone MetastasisCompletedNCT00035997Phase 4
- Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone LesionsCompletedNCT00029224Phase 4
- Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast CancerCompletedNCT00022087Phase 3
- Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No SymptomsTerminatedNCT00005073Phase 3
- Zoledronate in Treating Patients With Solid Tumors That Have Spread to the BoneCompletedNCT00003884Phase 3